Cytokinetics News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

06.06.14	Cytokinetics Announces Two Presentations Relating to Tirasemtiv to be Presented at the 2014 Annual Spinal Muscular Atrophy Conference (GlobeNewswire)
02.06.14	Cytokinetics Announces Further Results from BENEFIT-ALS Relating to Effects Following Withdrawal of Tirasemtiv (GlobeNewswire)
28.05.14	Cytokinetics to Present at Upcoming Healthcare Conferences (GlobeNewswire)
27.05.14	Cytokinetics Announces Additional Data From BENEFIT-ALS to be Presented at the Joint Congress of European Neurology (GlobeNewswire)
21.05.14	Cytokinetics Announces Three Publications Relating to Tirasemtiv and the Impact of Skeletal Muscle Activation on Respiratory Function and Muscle Strength (GlobeNewswire)
15.05.14	Cytokinetics to Hold Annual Meeting of Stockholders (GlobeNewswire)
29.04.14	Cytokinetics Announces Additional Results from BENEFIT-ALS (GlobeNewswire)
25.04.14	Cytokinetics Announces Top-Line Results From BENEFIT-ALS (GlobeNewswire)
24.04.14	Cytokinetics to Announce First Quarter Results on May 6, 2014 (GlobeNewswire)
23.04.14	Cytokinetics to Host Investor Breakfast and Webcast Following Presentation of Results from BENEFIT-ALS (GlobeNewswire)
22.04.14	Cytokinetics Announces Results From BENEFIT-ALS Will Be Presented at the 66th Annual Meeting of the American Academy of Neurology (GlobeNewswire)
01.04.14	Cytokinetics to Present at the 13th Annual Needham Healthcare Conference (GlobeNewswire)
28.03.14	Cytokinetics Announces the Opening to Enrollment of the Expansion of COSMIC-HF (GlobeNewswire)
27.03.14	Cytokinetics Announces Initiation of Multiple Dose Phase I Clinical Trial of CK-2127107 (GlobeNewswire)
28.02.14	Cytokinetics to Present at Upcoming Healthcare Conferences (GlobeNewswire)
25.02.14	Cytokinetics Announces Closing of its Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares (GlobeNewswire)
20.02.14	Cytokinetics Announces pricing of $35.0 Million Public Offering of Common Stock (GlobeNewswire)
16.10.13	Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver (PR Newswire)
13.09.13	Critical Alerts For IBM, Cytokinetics, Freeport McMoran, Portfolio Recovery Associates, and Spectra Energy Released By InvestorsObserver (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V